Global investment firm KKR has completed the acquisition of Henry Schein, Inc. for an undisclosed amount, marking a significant corporate transaction in the global healthcare market. This is an outright purchase of the company by KKR, distinctly separate from any funding round activity. Henry Schein, a prominent Fortune 500 company and S&P 500 index member, is recognized as a leading solutions provider for healthcare professionals.
Henry Schein leverages a global network of over 25,000 Team Schein Members and advanced technology to serve more than one million customers across 33 countries and territories. The company provides a comprehensive portfolio of over 300 valued solutions spanning business, clinical, technology, and supply chain areas. These offerings support office-based dental and medical practitioners, dental laboratories, government and institutional clinics, helping to improve operational success and clinical outcomes. With a centralized and automated distribution network, Henry Schein offers access to more than 300,000 branded and corporate brand products, achieving $12.7 billion in sales during 2024.
This acquisition is strategically aligned with KKR’s investment focus on established market leaders with strong growth potential. KKR aims to build upon Henry Schein’s extensive infrastructure and expertise to further enhance its ability to deliver essential services and products to healthcare providers. The expected synergies stem from KKR’s financial and strategic acumen complementing Henry Schein’s deep operational capabilities and broad customer reach, solidifying its position in the evolving healthcare landscape.
Looking forward, the combined entity is positioned to continue its commitment to healthcare professionals globally, fostering innovation and efficiency within dental and medical practice environments. This ownership transition is anticipated to strengthen Henry Schein’s capacity to empower practitioners in providing quality patient care more effectively and consistently.